overactive bladder and lower limb spasticity. Botox (onabotulinumtoxinA) could be threatened by biosimilars in the coming years, as Mylan has this year received confirmation from the FDA that it ...

spasticity expert, states,“This article, describing the benefits of Botox as the standard of care for treatment of lower extremity spasticity in children with cerebral palsy, was written in 2010.

The FDA has approved Allergan’s Botox to treat lower-limb spasticity in children, further extending the use of the drug – widely used as a wrinkle treatment – in therapeutic indications.

Merz Therapeutics, a business of Merz Group and a leader in the field of neurotoxins, announced that Health Canada approved Xeomin (incobotulinumtoxinA) for the treatment of post-stroke lower limb ...